Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use
Olivier Épaulard, Marlyse Buisson, Benjamin Némoz, Marion Le Maréchal, Nicolas Terzi, Jean‐François Payen, Marie Froidure, Myriam Blanc, Anne-Laure Mounayar, Fanny Quénard, Isabelle Pierre, Patricia Pavèse, Raphaële Germi, Laurence Grossi, Sylvie Larrat, Pascal Poignard, Julien Lupo
Topics & Concepts
Persistence (discontinuity)AntibodyVirologyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyNeutralizing antibodyImmunityBiologyPandemic2019-20 coronavirus outbreakMedicineImmune systemInternal medicineOutbreakDiseaseInfectious disease (medical specialty)Geotechnical engineeringEngineeringSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing